Nordea Investment Management AB acquired a new stake in Global Medical REIT Inc (NYSE:GMRE) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 146,120 shares of the company’s stock, valued at approximately $1,434,000. Nordea Investment Management AB owned about 0.44% of Global Medical REIT as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also modified their holdings of GMRE. Financial Advantage Inc. bought a new stake in shares of Global Medical REIT during the first quarter worth $31,000. Daiwa Securities Group Inc. grew its stake in Global Medical REIT by 100.0% in the first quarter. Daiwa Securities Group Inc. now owns 3,800 shares of the company’s stock valued at $37,000 after acquiring an additional 1,900 shares during the period. BNP Paribas Arbitrage SA grew its stake in Global Medical REIT by 639.1% in the first quarter. BNP Paribas Arbitrage SA now owns 4,782 shares of the company’s stock valued at $47,000 after acquiring an additional 4,135 shares during the period. State of Alaska Department of Revenue grew its stake in Global Medical REIT by 19.9% in the first quarter. State of Alaska Department of Revenue now owns 7,412 shares of the company’s stock valued at $72,000 after acquiring an additional 1,229 shares during the period. Finally, Nisa Investment Advisors LLC acquired a new position in Global Medical REIT in the first quarter valued at about $85,000. Hedge funds and other institutional investors own 51.97% of the company’s stock.
A number of research firms have issued reports on GMRE. Stifel Nicolaus began coverage on SkyWest in a research note on Monday, April 15th. They issued a “buy” rating and a $68.00 target price for the company. ValuEngine cut Zumiez from a “hold” rating to a “sell” rating in a research report on Tuesday, July 2nd. TheStreet cut Trade Desk from a “b-” rating to a “c-” rating in a research report on Thursday, May 9th. Zacks Investment Research raised General Moly from a “sell” rating to a “hold” rating in a research report on Thursday, July 11th. Finally, Boenning Scattergood set a $21.00 price objective on Essential Properties Realty Trust and gave the stock a “buy” rating in a research report on Friday, May 10th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $10.67.
Global Medical REIT (NYSE:GMRE) last announced its earnings results on Wednesday, May 8th. The company reported $0.02 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.20 by ($0.18). The firm had revenue of $15.20 million for the quarter, compared to the consensus estimate of $15.32 million. Global Medical REIT had a return on equity of 5.52% and a net margin of 21.38%. On average, equities research analysts predict that Global Medical REIT Inc will post 0.77 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Thursday, July 11th. Stockholders of record on Wednesday, June 26th were paid a dividend of $0.20 per share. The ex-dividend date was Tuesday, June 25th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 7.75%. Global Medical REIT’s dividend payout ratio (DPR) is currently 102.56%.
Global Medical REIT Company Profile
Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Featured Story: What is a resistance level?
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.